Latest news, press releases, and technical articles from Epistra Inc.https://epistra.jp/enhttps://epistra.jp/en/news/epistra_ip_base_award_2026_grandprix/https://epistra.jp/en/news/epistra_ip_base_award_2026_grandprix/On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.Tue, 10 Mar 2026 00:00:00 GMThttps://epistra.jp/en/news/epistra_ai_drug_discovery_book_2026/https://epistra.jp/en/news/epistra_ai_drug_discovery_book_2026/In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.Thu, 05 Mar 2026 00:00:00 GMThttps://epistra.jp/en/news/epistra_cell_manufacturing_symposium_2026/https://epistra.jp/en/news/epistra_cell_manufacturing_symposium_2026/On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.Wed, 04 Mar 2026 00:00:00 GMThttps://epistra.jp/en/news/media_ai_media/https://epistra.jp/en/news/media_ai_media/The 'AI Custom Medium Development Service,' a joint service with Shimadzu Corporation and Shimadzu Diagnostics Corporation announced on February 19, 2026, was covered by numerous media outlets including Nikkei.Fri, 27 Feb 2026 00:00:00 GMThttps://epistra.jp/en/news/ai_custom_media_development_service_shimadzu/https://epistra.jp/en/news/ai_custom_media_development_service_shimadzu/Epistra has launched the 'AI Custom Media Development Service' in collaboration with Shimadzu Corporation and Shimadzu Diagnostics, providing an integrated solution from AI-optimized culture medium composition design to custom medium manufacturing.Thu, 19 Feb 2026 00:00:00 GMThttps://epistra.jp/en/news/epistra_ip_base_award_2026_finalist/https://epistra.jp/en/news/epistra_ip_base_award_2026_finalist/Epistra Inc. has been selected as one of four finalists in the startup category of the '7th IP BASE AWARD' hosted by the Japan Patent Office.Tue, 17 Feb 2026 00:00:00 GMThttps://epistra.jp/en/news/epistra_rink_festival_2026/https://epistra.jp/en/news/epistra_rink_festival_2026/At 'RINK FESTIVAL 2026' held on February 6, 2026, CEO Yosuke Ozawa participated in Session B 'Innovation Magnet Power through the Spirit of Public Service,' discussing the industrialization of regenerative medicine.Fri, 13 Feb 2026 00:00:00 GMThttps://epistra.jp/en/news/medical-ai-contest-7-kickoff-ozawa/https://epistra.jp/en/news/medical-ai-contest-7-kickoff-ozawa/Epistra CEO Yosuke Ozawa presented at the kickoff event of the 7th National Medical AI Contest held on December 27, 2025.Mon, 05 Jan 2026 00:00:00 GMThttps://epistra.jp/en/news/jaact2025-osaka/https://epistra.jp/en/news/jaact2025-osaka/Epistra exhibited at JAACT2025 held in Osaka from December 8-11, 2025, presenting AI-powered optimization technology for experimental and culture conditions.Mon, 15 Dec 2025 00:00:00 GMThttps://epistra.jp/en/news/scarda_forum_2025_11/https://epistra.jp/en/news/scarda_forum_2025_11/On November 26, 2025, Epistra exhibited at the AMED-hosted 'SCARDA Joint Forum 2025,' participating in the sharing of vaccine research outcomes and deepening industry-academia collaboration.Mon, 01 Dec 2025 00:00:00 GMThttps://epistra.jp/en/news/epistra-hitachi-fermenta-s-reticuline-ai-optimization/https://epistra.jp/en/news/epistra-hitachi-fermenta-s-reticuline-ai-optimization/Epistra, Hitachi, and Fermenta leveraged AI-driven optimization and simulation technologies to achieve a world-leading yield of 6.0 g/L for the pharmaceutical intermediate (S)-reticuline, reducing the number of lab experiments by up to 73%.Thu, 27 Nov 2025 00:00:00 GMThttps://epistra.jp/en/news/fluoview-smart-fv5000-epistra-evident-ai-microscope/https://epistra.jp/en/news/fluoview-smart-fv5000-epistra-evident-ai-microscope/Epistra and Evident jointly developed an AI object search system. The next-generation confocal laser scanning microscope FLUOVIEW FV5000, equipped with the AI-powered software FLUOVIEW Smart, has been launched.Thu, 20 Nov 2025 00:00:00 GMThttps://epistra.jp/en/news/laboratory-automation-202511/https://epistra.jp/en/news/laboratory-automation-202511/Epistra CTO Taku Tsuzuki gave a presentation on 'Adaptive Experimental Design in Life Sciences' and 'Trends in AI Optimization' at the Laboratory Automation Monthly Study Group.Tue, 18 Nov 2025 00:00:00 GMThttps://epistra.jp/en/news/shinagawa-ecosystem-meetup-2025/https://epistra.jp/en/news/shinagawa-ecosystem-meetup-2025/On November 4, 2025, Epistra CEO Yosuke Ozawa delivered a pitch at the Shinagawa City-hosted 'Shinagawa Ecosystem Meetup #2,' presenting on AI optimization technology and the startup ecosystem.Wed, 05 Nov 2025 00:00:00 GMThttps://epistra.jp/en/news/jaact38-presentation/https://epistra.jp/en/news/jaact38-presentation/Epistra CEO Yosuke Ozawa presented at the symposium 'Cell Manufacturing with AI and Robotics' at the 38th Annual Conference of the Japanese Society for Alternatives to Animal Experiments.Tue, 04 Nov 2025 00:00:00 GMThttps://epistra.jp/en/news/epistra-appearances-2025-apr-oct/https://epistra.jp/en/news/epistra-appearances-2025-apr-oct/A summary report of Epistra's speaking engagements at academic conferences and symposiums, and exhibition activities from April to October 2025.Fri, 17 Oct 2025 00:00:00 GMThttps://epistra.jp/en/news/black-box-optimization-review-2025/https://epistra.jp/en/news/black-box-optimization-review-2025/A review paper on black-box optimization co-authored by Chiba University, Kyoto University, and Epistra has been published in Allergology International. It is a practical guide that systematically organizes BBO methods for the life sciences.Thu, 02 Oct 2025 00:00:00 GMThttps://epistra.jp/en/news/exhibit_jhvs2025/https://epistra.jp/en/news/exhibit_jhvs2025/Epistra will exhibit at the Japan Healthcare Venture Summit (JHVS), co-located with BioJapan 2025, held October 8-10 at Pacifico Yokohama.Wed, 01 Oct 2025 00:00:00 GMThttps://epistra.jp/en/tech-blog/medium-optimization-bayesian-vs-doe/https://epistra.jp/en/tech-blog/medium-optimization-bayesian-vs-doe/We review a paper comparing Bayesian optimization (BBO) and Design of Experiments (DoE) for medium optimization, discussing how BBO achieved over 1.5-fold performance improvement over DoE and the factors behind this result.Wed, 01 Oct 2025 00:00:00 GMThttps://epistra.jp/en/tech-blog/batch-bayesian-optimization-medium-components/https://epistra.jp/en/tech-blog/batch-bayesian-optimization-medium-components/We present a practical implementation of batch Bayesian optimization and explain the trade-off between search accuracy and experimental efficiency through a comparison with sequential optimization.Wed, 01 Oct 2025 00:00:00 GMThttps://epistra.jp/en/tech-blog/sequential-bayesian-optimization-medium-components/https://epistra.jp/en/tech-blog/sequential-bayesian-optimization-medium-components/Using a function that simulates cell behavior in response to medium component concentrations, we explain the sequential optimization approach of Bayesian optimization and illustrate the expected results with a Python implementation.Wed, 01 Oct 2025 00:00:00 GMThttps://epistra.jp/en/news/cira-scientific-reports-2025/https://epistra.jp/en/news/cira-scientific-reports-2025/A method for early, non-destructive prediction of differentiation efficiency from human iPSCs to muscle stem cells, jointly developed by Epistra and Kyoto University's Center for iPS Cell Research and Application (CiRA), has been published in Scientific Reports.Fri, 25 Jul 2025 00:00:00 GMThttps://epistra.jp/en/news/interview_update_astellas/https://epistra.jp/en/news/interview_update_astellas/Updated interview article on how Astellas Pharma achieved a 50-100x yield improvement in their NK cell differentiation process optimization using Epistra's AI and robotics.Mon, 07 Jul 2025 00:00:00 GMThttps://epistra.jp/en/news/interfexweek2025_pharmadx/https://epistra.jp/en/news/interfexweek2025_pharmadx/Epistra will exhibit at the Pharma DX Expo within INTERPHEX Week 2025, held July 9-11 at Tokyo Big Sight. CEO Ozawa will also give an exclusive seminar.Wed, 25 Jun 2025 00:00:00 GMThttps://epistra.jp/en/news/update_qbd/https://epistra.jp/en/news/update_qbd/Epistra Accelerate now features a new QbD Process Development function that simultaneously identifies robust conditions against instability and estimates the design space.Tue, 27 May 2025 00:00:00 GMThttps://epistra.jp/en/news/jaact_symposium_2025/https://epistra.jp/en/news/jaact_symposium_2025/Epistra CEO Yosuke Ozawa presented on the theme of 'AI x Bioproduction' at the 50th Animal Cell Technology Symposium held at Nihonbashi Life Science Building on May 12, 2025.Mon, 19 May 2025 00:00:00 GMThttps://epistra.jp/en/news/office-relocation-2025/https://epistra.jp/en/news/office-relocation-2025/Epistra Inc. relocated its head office to Osaki Bright Core in Kita-Shinagawa, Shinagawa-ku, Tokyo, effective May 1, 2025.Fri, 02 May 2025 00:00:00 GMThttps://epistra.jp/en/news/india-japan-meeting-on-the-nobel-turing-challenge/https://epistra.jp/en/news/india-japan-meeting-on-the-nobel-turing-challenge/CEO Yosuke Ozawa presented on autonomous optimization of life science experiments at the India-Japan Nobel Turing Challenge Meeting (IJNTC2025) held in Tokyo on March 24-25, 2025.Wed, 26 Mar 2025 00:00:00 GMThttps://epistra.jp/en/news/jsrm25_astellas/https://epistra.jp/en/news/jsrm25_astellas/At a luncheon seminar of the 24th Annual Meeting of the Japanese Society for Regenerative Medicine, we reported on results from joint research with Astellas Pharma combining the automated experiment robot 'Mahoro' and AI 'Epistra Accelerate' for stem cell culture condition optimization.Wed, 19 Mar 2025 00:00:00 GMThttps://epistra.jp/en/news/2nd-amed-scarda/https://epistra.jp/en/news/2nd-amed-scarda/At the 2nd AMED SCARDA Joint Symposium held from March 17-19, 2025 at the Kobe International Conference Center, we presented a corporate exhibition and poster on autonomous optimization of vaccine development processes using AI.Tue, 18 Mar 2025 00:00:00 GMThttps://epistra.jp/en/news/japan-innovation-day-2025/https://epistra.jp/en/news/japan-innovation-day-2025/We exhibited at 'JAPAN INNOVATION DAY 2025 by ASCII STARTUP' held on February 28, 2025, presenting our AI optimization solution 'Epistra Accelerate.' CEO Ozawa also delivered a startup pitch.Sat, 01 Mar 2025 00:00:00 GMThttps://epistra.jp/en/news/rink-festival-2025/https://epistra.jp/en/news/rink-festival-2025/On February 14, 2025, CEO Yosuke Ozawa spoke at the Kanagawa Prefecture-hosted 'RINK FESTIVAL 2025,' presenting on AI-driven culture condition optimization and integration with robotics technology in the session 'The Future of Regenerative Medicine Opened by AI.'Sat, 15 Feb 2025 00:00:00 GMThttps://epistra.jp/en/news/jhvs2024/https://epistra.jp/en/news/jhvs2024/We will exhibit at the Japan Healthcare Venture Summit (JHVS) at Pacifico Yokohama, Booth V-22. CEO Yosuke Ozawa will also deliver a pitch at the JHVS SHOWCASE.Tue, 08 Oct 2024 00:00:00 GMThttps://epistra.jp/en/news/media_celltune/https://epistra.jp/en/news/media_celltune/CellTune, a product jointly developed with Shimadzu Corporation and released on September 4, 2024, was featured in multiple media outlets including Nikkei Biotechnology, The Chemical Daily, and ASCII.Wed, 18 Sep 2024 00:00:00 GMThttps://epistra.jp/en/news/synthetic_igem_2024/https://epistra.jp/en/news/synthetic_igem_2024/On September 9, 2024, our CTO Tsuzuki spoke at the 76th Annual Meeting of the Society for Biotechnology, Japan symposium 'Human Resource Development Through the International Synthetic Biology Student Competition iGEM.'Thu, 12 Sep 2024 00:00:00 GMThttps://epistra.jp/en/news/celltune_release/https://epistra.jp/en/news/celltune_release/Epistra and Shimadzu Corporation have launched the co-developed cell culture optimization software 'CellTune.' It leverages LC-MS data and AI technology to automatically propose optimal culture conditions.Wed, 04 Sep 2024 00:00:00 GMThttps://epistra.jp/en/news/phamalab_2024/https://epistra.jp/en/news/phamalab_2024/We will be exhibiting at the 6th Pharma Lab EXPO Tokyo, held at Tokyo Big Sight from June 26-28, 2024.Tue, 18 Jun 2024 00:00:00 GMThttps://epistra.jp/en/news/myoridge_epistra_mscmedium/https://epistra.jp/en/news/myoridge_epistra_mscmedium/Epistra and Myoridge jointly leveraged AI technology to successfully develop culture media for mesenchymal stem cells (MSCs), discovering 75 medium compositions with superior proliferative properties in approximately 4 months.Wed, 08 May 2024 00:00:00 GMThttps://epistra.jp/en/news/r4_tokyo_innovation/https://epistra.jp/en/news/r4_tokyo_innovation/Epistra Inc. has been selected for the 'TOKYO Strategic Innovation Promotion Program' by the Tokyo Metropolitan Small and Medium Enterprise Support Center, receiving up to 80 million yen over three years to advance AI-driven R&D efficiency.Wed, 13 Sep 2023 00:00:00 GMThttps://epistra.jp/en/news/zikkenigaku_2023/https://epistra.jp/en/news/zikkenigaku_2023/An article by Ozawa and Tsuzuki titled 'Integration of Public Omics Data and Hypothesis Generation Based on OSINT' has been published in Yodosha's 'Jikken Igaku Supplement: Multi-omics — Disease Research in the Data-Driven Era.'Wed, 13 Sep 2023 00:00:00 GMThttps://epistra.jp/en/news/regenerative_medicine_2023/https://epistra.jp/en/news/regenerative_medicine_2023/We will be exhibiting at the 22nd Annual Meeting of the Japanese Society for Regenerative Medicine, held at the Kyoto International Conference Center from March 23, 2023.Sun, 12 Mar 2023 00:00:00 GMThttps://epistra.jp/en/news/phamalab_2023/https://epistra.jp/en/news/phamalab_2023/We will be exhibiting at the 3rd Pharma Lab EXPO (interphex) Osaka, held at INTEX Osaka from March 8-10, 2023.Mon, 06 Mar 2023 00:00:00 GMThttps://epistra.jp/en/news/sale-solution_rbi/https://epistra.jp/en/news/sale-solution_rbi/Epistra and Robotic Biology Institute (RBI) have agreed to jointly sell an integrated solution combining RBI's robot 'LabDroid Mahoro' for cell culture experiment automation with Epistra's AI optimization solution 'Epistra Accelerate.'Thu, 09 Feb 2023 00:00:00 GMThttps://epistra.jp/en/news/iot-h-w-biz-day-2022/https://epistra.jp/en/news/iot-h-w-biz-day-2022/We will exhibit at 'IoT H/W BIZ DAY 2022,' an advanced technology business conference organized by ASCII STARTUP, and CEO Yosuke Ozawa will speak at the startup showcase on December 16.Wed, 07 Dec 2022 00:00:00 GMThttps://epistra.jp/en/news/r4_global_nitch/https://epistra.jp/en/news/r4_global_nitch/Epistra Inc. has been selected for the 'Global Niche Top Subsidy Program' administered by the Tokyo Metropolitan Small and Medium Enterprise Support Center, receiving up to 10 million yen over three years for intellectual property acquisition and maintenance.Tue, 29 Nov 2022 00:00:00 GMThttps://epistra.jp/en/news/forbes-japan_ipscell/https://epistra.jp/en/news/forbes-japan_ipscell/Our collaborative work with Dr. Masayo Takahashi and colleagues, published as a paper in June 2022, was featured in Forbes Japan under the title 'iPS Cell Culture is a Master Craftsman's Art -- AI-Created Recipes Inherited by Robots.'Wed, 09 Nov 2022 00:00:00 GMThttps://epistra.jp/en/news/jhvs_2022/https://epistra.jp/en/news/jhvs_2022/We have been selected to exhibit at the 'Japan Healthcare Venture Summit (JHVS) 2022' organized by the Ministry of Health, Labour and Welfare, and will have a booth at Pacifico Yokohama from October 12-14.Sat, 24 Sep 2022 00:00:00 GMThttps://epistra.jp/en/news/zikkennigaku_ai-robot_2022/https://epistra.jp/en/news/zikkennigaku_ai-robot_2022/An article introducing our joint research paper with RIKEN, 'Robotic search for optimal cell culture in regenerative medicine,' will be published in the September 2022 issue of Yodosha's Jikken Igaku (Experimental Medicine).Mon, 22 Aug 2022 00:00:00 GMThttps://epistra.jp/en/news/ipas2022/https://epistra.jp/en/news/ipas2022/Epistra Inc. has been selected as a supported company in the Japan Patent Office's IP Acceleration Program 'IPAS2022,' and will build an IP strategy linked to business strategy through approximately 5 months of IP mentoring.Tue, 09 Aug 2022 00:00:00 GMThttps://epistra.jp/en/news/elife_rilken/https://epistra.jp/en/news/elife_rilken/A commentary article on the joint research paper with RIKEN, 'Robotic search for optimal cell culture in regenerative medicine,' published in the British journal eLife, has been released by the same journal.Sun, 31 Jul 2022 00:00:00 GMThttps://epistra.jp/en/news/elife_optimal-cell-culture/https://epistra.jp/en/news/elife_optimal-cell-culture/In a joint research project with RIKEN and RBI, we successfully achieved automated optimization of a differentiation induction protocol from iPSCs to retinal pigment epithelial cells by combining an experimental robot with AI 'Epistra Accelerate,' and the results were published in the journal eLife.Sun, 26 Jun 2022 00:00:00 GMThttps://epistra.jp/en/news/nikkei_spiber/https://epistra.jp/en/news/nikkei_spiber/Our collaborative research with Spiber was featured in the Nikkei Sangyo Shimbun. The joint research, which began in 2020, has reportedly reduced timelines from two years to just a few weeks.Fri, 20 May 2022 00:00:00 GMThttps://epistra.jp/en/news/scientificreport_2022/https://epistra.jp/en/news/scientificreport_2022/Joint research between Epistra and Kobe City Eye Center Hospital led to the development of software for automated evaluation of retinal pigment epithelium disease areas using deep learning, published in the international journal 'Scientific Reports.'Sat, 26 Mar 2022 00:00:00 GMThttps://epistra.jp/en/news/shimadzu_solution/https://epistra.jp/en/news/shimadzu_solution/Epistra and Shimadzu Corporation have agreed to jointly develop a cell culture condition optimization solution combining LC/MS/MS analysis technology with AI 'Epistra Accelerate,' targeting commercialization in 2024.Mon, 21 Feb 2022 00:00:00 GMThttps://epistra.jp/en/news/nvidia-inception-program-partner/https://epistra.jp/en/news/nvidia-inception-program-partner/Epistra has been certified as a partner of NVIDIA Corporation's AI startup support program 'NVIDIA Inception Program,' and will strengthen the development of its automated experimental design AI 'Epistra Accelerate.'Mon, 14 Feb 2022 00:00:00 GMThttps://epistra.jp/en/news/minatoku_subsidy/https://epistra.jp/en/news/minatoku_subsidy/We were selected for Minato City's 'FY2021 New Product and New Technology Development Subsidy Program' for our project on developing an indicator estimation system for optimizing culture conditions using cell culture medium analysis data.Mon, 06 Sep 2021 00:00:00 GMThttps://epistra.jp/en/news/ascii-startup-ichioshi/https://epistra.jp/en/news/ascii-startup-ichioshi/Epistra was featured as the 'Pick of the Week' on ASCII STARTUP media.Tue, 23 Mar 2021 00:00:00 GMThttps://epistra.jp/en/news/pictch_nikkei_2020/https://epistra.jp/en/news/pictch_nikkei_2020/We participated in the Tokyo block of 'Sta★Ato Pitch Japan,' a pitch contest hosted by Nikkei. The pitch is available for viewing online.Wed, 17 Mar 2021 00:00:00 GMThttps://epistra.jp/en/news/nikkankougyo_takahashi/https://epistra.jp/en/news/nikkankougyo_takahashi/An article by co-founder Koichi Takahashi titled 'Opinion / RIKEN Team Leader Koichi Takahashi: Industrial Revolution through Establishing Scientific AI' was published in the digital edition of Nikkan Kogyo Shimbun.Tue, 16 Mar 2021 00:00:00 GMThttps://epistra.jp/en/news/rink_2020/https://epistra.jp/en/news/rink_2020/On December 9, 2020, CEO Ozawa spoke online at the RINK Public Forum 2020 'Collaboration Between Digital Technology and Regenerative Medicine.'Tue, 05 Jan 2021 00:00:00 GMThttps://epistra.jp/en/news/mirai2021/https://epistra.jp/en/news/mirai2021/We were selected as one of the 30 finalists for 'Mirai 2021,' one of Japan's largest acceleration programs co-hosted by Sumitomo Mitsui Banking Corporation and Mirai Works.Mon, 04 Jan 2021 00:00:00 GMThttps://epistra.jp/en/news/jst_robotic-biology/https://epistra.jp/en/news/jst_robotic-biology/The JST Mirai Program project 'Accelerating Life Science through Robotic Biology' has been selected as a new full-scale research project for FY2020, and we will participate as a collaborative research institution.Mon, 07 Dec 2020 00:00:00 GMThttps://epistra.jp/en/news/ladec2020/https://epistra.jp/en/news/ladec2020/We sponsored the Laboratory Automation Developers Conference 2020 (LADEC2020), held online on October 2-3.Sun, 04 Oct 2020 00:00:00 GMThttps://epistra.jp/en/news/transfer_main/https://epistra.jp/en/news/transfer_main/We have relocated our head office in conjunction with our continued remote work policy. In response to the spread of COVID-19, we implemented company-wide remote work and will continue operating under a remote-first work structure.Thu, 01 Oct 2020 00:00:00 GMThttps://epistra.jp/en/news/kobe-eyecenter_hospital/https://epistra.jp/en/news/kobe-eyecenter_hospital/We have started joint research with Kobe Eye Center Hospital on 'Integrated Analysis of Fundus Findings in Eye Diseases,' aiming to develop a diagnostic support system for retinal diseases using AI and machine learning.Wed, 09 Sep 2020 00:00:00 GMThttps://epistra.jp/en/news/microsoft-for-startups/https://epistra.jp/en/news/microsoft-for-startups/We have been accepted into Microsoft's startup support program 'Microsoft for Startups.' We will accelerate the development of an automated optimization system for life science experimental protocols using Microsoft Azure.Wed, 29 Jul 2020 00:00:00 GMThttps://epistra.jp/en/news/communications-of-acm/https://epistra.jp/en/news/communications-of-acm/An article by CEO Ozawa titled 'Challenge Yourself by Reaching for the Highest Bar' was published in the July 2020 issue of Communications of the ACM.Wed, 01 Jul 2020 00:00:00 GMThttps://epistra.jp/en/news/riken-rbi-kyoudoukennkyuu/https://epistra.jp/en/news/riken-rbi-kyoudoukennkyuu/We have signed a three-party joint research agreement with RIKEN and Robotic Biology Institute (RBI) for the development of foundational technology for a next-generation autonomous cell culture system driven by robotics.Wed, 13 May 2020 00:00:00 GMThttps://epistra.jp/en/news/estonia_-reception/https://epistra.jp/en/news/estonia_-reception/CEO Ozawa delivered a pitch at the welcome reception for the Estonian Prime Minister's delegation held in Kobe on February 13, 2020, introducing our services and initiatives.Thu, 13 Feb 2020 00:00:00 GMThttps://epistra.jp/en/news/xtc-japan-competition-2020-finalist/https://epistra.jp/en/news/xtc-japan-competition-2020-finalist/We were selected as one of 10 finalists in the Japan qualifying round of the Extreme Tech Challenge (XTC), the world's largest startup competition for social entrepreneurs addressing the SDGs.Fri, 07 Feb 2020 00:00:00 GMThttps://epistra.jp/en/news/third-party-allotment/https://epistra.jp/en/news/third-party-allotment/We completed a third-party allotment of shares, bringing our capital (including capital reserves) to 34,990 thousand yen.Fri, 31 Jan 2020 00:00:00 GMThttps://epistra.jp/en/news/500-kobe-accelarator-demo-day/https://epistra.jp/en/news/500-kobe-accelarator-demo-day/CEO Ozawa delivered a pitch at the demo day of 500 KOBE ACCELERATOR, a program jointly run by the City of Kobe and 500 Startups.Mon, 16 Dec 2019 00:00:00 GMThttps://epistra.jp/en/news/third-party-allotment_2019/https://epistra.jp/en/news/third-party-allotment_2019/We completed a third-party allotment of shares with Hiroaki Kitano and others as subscribers, bringing our capital to 14,980 thousand yen.Tue, 10 Dec 2019 00:00:00 GMThttps://epistra.jp/en/news/500kobe/https://epistra.jp/en/news/500kobe/We passed the selection process for '500 KOBE ACCELERATOR,' a startup acceleration program co-hosted by the City of Kobe and 500 Startups, and will participate in the six-week program starting November 4.Thu, 24 Oct 2019 00:00:00 GMThttps://epistra.jp/en/news/riken-bdr_summerschool/https://epistra.jp/en/news/riken-bdr_summerschool/At the summer school hosted by RIKEN Center for Biosystems Dynamics Research (BDR), our CTO Tsuzuki delivered a lecture on 'Automated Optimization of Experimental Protocols Using Bayesian Optimization.'Fri, 06 Sep 2019 00:00:00 GMT